InterCure Ltd banner
I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 272 ILS -4.23% Market Closed
Market Cap: ₪130.8m

Profitability Summary

InterCure Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
InterCure Ltd

Margins Comparison
InterCure Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IL
InterCure Ltd
TASE:INCR
130.8m ILS
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
997.2B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
281.1B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
303.5B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
230.9B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.1B GBP
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.7B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
InterCure Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IL
InterCure Ltd
TASE:INCR
130.8m ILS
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
997.2B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
281.1B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
303.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
230.9B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.1B GBP
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.7B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
InterCure Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate